Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

JM Ringman, A Goate, CL Masters, NJ Cairns… - Current neurology and …, 2014 - Springer
Since the original publication describing the illness in 1907, the genetic understanding of
Alzheimer's disease (AD) has advanced such that it is now clear that it is a genetically …

[HTML][HTML] Arizona study of aging and neurodegenerative disorders and brain and body donation program

TG Beach, CH Adler, LI Sue, G Serrano… - … : official journal of the …, 2015 - ncbi.nlm.nih.gov
Abstract The Brain and Body Donation Program (BBDP) at Banner Sun Health Research
Institute (http://www. brainandbodydonationprogram. org) started in 1987 with brain-only …

Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging

AR Hoy, M Ly, CM Carlsson, OC Okonkwo… - PloS one, 2017 - journals.plos.org
Brain changes associated with Alzheimer's disease (AD) begin decades before disease
diagnosis. While β-amyloid plaques and neurofibrillary tangles are defining features of AD …

PERK activation mitigates tau pathology in vitro and in vivo

J Bruch, H Xu, TW Rösler, A De Andrade… - EMBO molecular …, 2017 - embopress.org
The RNA‐like endoplasmic reticulum kinase (PERK) is genetically associated with the
tauopathy progressive supranuclear palsy (PSP). To elucidate the functional mechanisms …

PSEN1 c.1292C<A Variant and Early-Onset Alzheimer's Disease: A Scoping Review

M Orozco-Barajas, Y Oropeza-Ruvalcaba… - Frontiers in Aging …, 2022 - frontiersin.org
Alzheimer's disease (AD) is the most common cause of dementia, characterized by
progressive loss of cognitive function, with β-amyloid plaques and neurofibrillary tangles …

Alzheimer's disease neuropathological comorbidities are common in the younger-old

TG Beach, M Malek-Ahmadi - Journal of Alzheimer's Disease, 2021 - content.iospress.com
Background: Clinicopathological studies have demonstrated that Alzheimer's disease
dementia (ADD) is often accompanied by clinically undetectable comorbid …

Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease …

D Sepulveda-Falla, CA Villegas Lanau… - … of Neuropathology & …, 2025 - academic.oup.com
Studying comorbidities in early onset Alzheimer disease (AD) may provide an advantageous
perspective on their pathogenesis because aging factors may be largely inoperative for …

Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease

JB Nichols, M Malek-Ahmadi, PN Tariot… - … of Neuropathology & …, 2021 - academic.oup.com
We sought to determine the associations among cerebral amyloid angiopathy (CAA), white
matter rarefaction (WMR), circle of Willis atherosclerosis (CWA), and total microinfarct …

Genetic phenotypes of alzheimer's disease: Mechanisms and potential therapy

M Quan, S Cao, Q Wang, S Wang, J Jia - Phenomics, 2023 - Springer
Years of intensive research has brought us extensive knowledge on the genetic and
molecular factors involved in Alzheimer's disease (AD). In addition to the mutations in the …

Widespread white matter and conduction defects in PSEN1-related spastic paraparesis

SK Soosman, N Joseph-Mathurin, MN Braskie… - Neurobiology of …, 2016 - Elsevier
The mechanisms underlying presenilin 1 (PSEN1) mutation–associated spastic paraparesis
(SP) are not clear. We compared diffusion and volumetric magnetic resonance measures …